Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01PZU
|
||||
Former ID |
DNC007991
|
||||
Drug Name |
N-ethyl-5,6-dip-tolylpyrazine-2-carboxamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528851] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H21N3O
|
||||
Canonical SMILES |
CCNC(=O)C1=CN=C(C(=N1)C2=CC=C(C=C2)C)C3=CC=C(C=C3)C
|
||||
InChI |
1S/C21H21N3O/c1-4-22-21(25)18-13-23-19(16-9-5-14(2)6-10-16)20(24-18)17-11-7-15(3)8-12-17/h5-13H,4H2,1-3H3,(H,22,25)
|
||||
InChIKey |
BAXIFQMQEGUGGQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [528851] | |
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.